MetLife Investment Management LLC Decreases Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• MetLife Investment Management LLC reduced its stake in Synopsys, Inc. by 1.0%, now holding 46,858 shares valued at approximately $20.1 million.
• Multiple hedge funds increased their positions in Synopsys, with Cornerstone Planning Group LLC raising its holdings by 275.0% in the same quarter.
• Wall Street analysts are bullish on Synopsys, with price targets ranging from $610.00 to $715.00, indicating a consensus rating of "Moderate Buy."

MetLife Investment Management LLC trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,858 shares of the semiconductor company's stock after selling 487 shares during the period. MetLife Investment Management LLC's holdings in Synopsys were worth $20,095,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Cornerstone Planning Group LLC raised its holdings in shares of Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock worth $25,000 after acquiring an additional 44 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after buying an additional 53 shares during the period. Ameriflex Group Inc. purchased a new stake in Synopsys during the 4th quarter valued at $29,000. Cloud Capital Management LLC purchased a new stake in Synopsys during the 1st quarter valued at $36,000. Finally, Meeder Asset Management Inc. raised its holdings in Synopsys by 33.3% during the 1st quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock valued at $45,000 after buying an additional 26 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SNPS. KeyCorp increased their price target on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a report on Thursday, July 10th. Needham & Company LLC restated a "buy" rating and set a $660.00 price target (up previously from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Piper Sandler increased their price target on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a report on Monday, July 21st. Rosenblatt Securities increased their price target on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a report on Friday, July 25th. Finally, Morgan Stanley restated an "overweight" rating and set a $715.00 price target (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Twelve equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $626.79.

Synopsys Stock Performance

Shares of Synopsys stock opened at $606.52 on Monday. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $94.11 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 3.99 and a beta of 1.15. The stock's fifty day moving average is $570.29 and its two-hundred day moving average is $500.54. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.60 billion. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.Synopsys's quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.00 earnings per share. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Activity

In other news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the transaction, the chief executive officer owned 71,589 shares in the company, valued at approximately $32,782,750.77. This trade represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive owned 1,485 shares in the company, valued at approximately $699,746.85. This represents a 85.85% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,686 shares of company stock worth $13,001,048. Company insiders own 0.62% of the company's stock.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.